The first serine protease inhibitor from Lasiodora sp (Araneae: Theraphosidae) hemocytes

Soares, Tatiana; Ferreira, Felipe Roberto Borba; Gomes, Francis Soares; Coelho, Luana Cassandra Breitenbach Barroso; Torquato, Ricardo José Soares [UNIFESP]; Napoleão, Thiago Henrique; Cavalcanti, Maria do Socorro de Mendonça; Tanaka, Aparecida Sadae [UNIFESP]; Paiva, Patricia Maria Guedes

The first serine protease inhibitor from Lasiodora sp (Araneae: Theraphosidae) hemocytes

Arquivos

WOS000297832000014.pdf(423.86 KB)

Data

2011-12-01

Autores

Soares, Tatiana

Ferreira, Felipe Roberto Borba

Gomes, Francis Soares

Coelho, Luana Cassandra Breitenbach Barroso

Torquato, Ricardo José Soares

Mostrar mais

Tipo

Artigo

Resumo

This work reports, for the first time, the purification, characterization and antibacterial activity of an elastase inhibitor from Lasiodora sp. hemocytes (ElLaH). the hemocyte extract inhibited chymotrypsin (22%). trypsin (44%), tissue plasminogen activator (52%), urokinase (58%) and human neutrophil elastase (99%). ElLaH was purified by Trypsin-Sepharose column and RP-HPLC. SDS-PAGE of ElLaH revealed a molecular mass of 8 kDa and MALDI-TOF mass spectrometry revealed a single molecular mass of 8274 Da. the amino terminal sequence determined was LPC(PF)PYQQELTC. the dissociation constant (K) for human neutrophil elastase was 0.32 nM. Hemocyte extract exerted antibacterial effect on Bacillus subtilis and Enterococcus faecalis, while ElLaH was only active against E. faecalis. Currently, Lasiodora sp. is undergoing a systematic review and this study contributes to molecular characterization of the genus. in addition, the results suggest that serine protease inhibitors expressed in Lasiodora sp. hemocytes may be involved in the defense against bacterial infection. (C) 2011 Elsevier B.V. All rights reserved.

Citação

Process Biochemistry. Oxford: Elsevier B.V., v. 46, n. 12, p. 2317-2321, 2011.